Application status and future prospect of transjugular intrahepatic portosystemic shunt in gastroesophageal variceal bleeding in liver cirrhosis
10.3969/j.issn.1001-5256.2022.06.004
- VernacularTitle:经颈静脉肝内门体分流术在肝硬化食管胃底静脉曲张破裂出血中的应用现状与未来展望
- Author:
Yong LYU
1
,
2
;
Daiming FAN
1
;
Guohong HAN
3
Author Information
1. Department of Gastroenterology, Xijing Hospital, Air Force Medical University, Xi'an 710032, China
2. Military Medical Innovation Center, Air Force Medical University, Xi'an 710032, China
3. Department of Digestive Intervention, Digestive Diseases Hospital, Xi'an International Medical Center Hospital, Xi'an 710100, China
- Publication Type:Discussions by Experts
- Keywords:
Liver Cirrhosis;
Portal Hypertension;
Portasystemic Shunt, Transjugular Intrahepatic;
Esophageal and Gastric Varices
- From:
Journal of Clinical Hepatology
2022;38(6):1229-1233
- CountryChina
- Language:Chinese
-
Abstract:
Gastroesophageal variceal bleeding is the life-threating complication of cirrhotic portal hypertension, and transjugular intrahepatic portosystemic shunt (TIPS) is an effective therapy for portal hypertension-related complications. TIPS can be used for the prevention of first-time bleeding in patients with recurrent or intractable ascites. TIPS should be performed as early as possible for patients at a high risk of acute variceal bleeding (Child-Pugh class C < 14 points or Child-Pugh class B > 7 points with active bleeding on endoscopy or hepatic venous pressure > 20 mmHg). TIPS is an effective salvage therapy for acute variceal bleeding with failure after standard treatment, and is also a second-line option for preventing variceal rebleeding.
